Description
The Veterans Health Administration’s Buffalo VA Medical Center is issuing a sole‑source, firm‑fixed‑price contract to Thermo Fisher Scientific for a set of Genexus reagents and consumables required to keep its Genexus NGS instrument operational for oncology testing. The procurement covers barcodes, pipette tips, plates, chips, sequencing kits, purification kits, and the Oncomine Precision Assay. While the award will be made without competition, other large‑business vendors may submit capability statements for consideration before the award date.
• Sole‑source award to Thermo Fisher Scientific (large business)
• Supplies for Thermo Fisher Genexus instrument and Oncomine Precision Assay
• Item quantities: e.g., 12 barcode sets, 6 sequencing kits, 12 assay kits, etc.
• Firm‑fixed‑price contract; no reimbursement for capability statements
• Capability statements due 10:00 AM EST August 27 2025 (or 2026 per later notice)
• Contract will support molecular‑guided cancer therapy at Buffalo VA